Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
CRIVO APP icon

2.1.0 by NUTES UFPE


Oct 6, 2023

About CRIVO APP

Simple tool for the critical analysis of scientific literature in health.

The application provides the main study designs with the specific items that must be observed to allow a careful analysis of the confidence in the results found. In the evidence-based clinical practice model, there is a need to formulate focused and objective clinical questions to answer existing doubts in patient care. Questions may vary, depending on the aspects to be explored, and involve questioning intervention, diagnosis, prognosis, damage or risk factor. Thus, to answer each clinical question, there is a more adequate methodological study model, which should be considered when searching the available evidence.

The application also has a calculator so that the main calculations of the magnitude of the effect of the treatment or diagnostic test can be carried out, as well as associations between variables. In addition, links to the main electronic databases in the health area can still be found in the perspective presented.

What's New in the Latest Version 2.1.0

Last updated on Oct 6, 2023

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request CRIVO APP Update 2.1.0

Requires Android

5.0

Available on

Get CRIVO APP on Google Play

Show More

CRIVO APP Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.